News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Gut microbiome may offer novel bacterial markers in kids with autism
By Lisa Rapaport (Reuters Health) - Children with autism spectrum disorder may have a distinctive and underdeveloped gut microbiome that isn't related to their eating habits, a small Chinese study
UPDATE 1-Biden sets broad new vaccine, mask guidelines for millions of federal workers
(Recasts with White House announcement) By David Shepardson, Jeff Mason and Steve Holland WASHINGTON (Reuters) - Federal workers and onsite contractors will have to show proof of vaccination against
Disparities in prostatectomy during first pandemic wave
By Lisa Rapaport (Reuters Health) - Black men with prostate cancer were significantly less likely to receive prostatectomy than white men during the early months of the COVID-19 pandemic, despite
Liver transplant a safe option after recovery from COVID-19
By Reuters Staff NEW YORK (Reuters Health) – Candidates for liver transplant (LT) who have symptomatic SARS-CoV-2 infection are at high risk of premature death – particularly those with decompensated
Survey finds high rates of infertility and pregnancy complications among female surgeons
By Linda Carroll (Reuters Health) - Female surgeons experience higher rates of infertility and pregnancy complications than women in the general population, a new study suggests. An analysis of survey
EXCLUSIVE-AstraZeneca exploring options for COVID-19 vaccine business - executive
By Alistair Smout and Pushkala Aripaka LONDON (Reuters) - AstraZeneca is exploring options for the future of its COVID-19 vaccine and expects greater clarity on the matter by the end of 2021, a senior
UPDATE 1-Israel to offer Pfizer booster shot against COVID-19 to the over-60s
(Adds comments by PM Bennett) By Reuters Staff JERUSALEM (Reuters) - Israel will begin offering a third shot of the Pfizer/BioNTech COVID-19 vaccine to people aged over 60, a world first in efforts to
Some young athletes with genetic heart disease can stay in the game, with appropriate care
By Megan Brooks NEW YORK (Reuters Health) - New data from the Mayo Clinic challenges the automatic benching of all athletes found to have a genetic heart disease (GHD) predisposing to sudden cardiac
U.S. school masks debate erupts anew weeks before classes resume
By Joseph Ax and Brad Brooks (Reuters) - In pandemic-pummeled Florida, angry parents clashed with Broward County school board members this week over whether their children will be forced to wear masks
Biden federal worker vaccination push to affect millions
By Reuters Staff WASHINGTON (Reuters) - U.S. President Joe Biden is expected to take a broad new step to fight the pandemic on Thursday by announcing that civilian federal government employees will
FDA notifies Amazon over sale of certain harmful sexual enhancement products
By Reuters Staff (Reuters) - The U.S Food and Drug Administration (FDA) notified Amazon.com Inc over the sale of sexual enhancement and weight-loss products that had potentially harmful drug
U.S. FDA allows Lilly's COVID-19 drug to be taken without remdesivir
By Reuters Staff (Reuters) - The U.S. health regulator expanded the emergency use authorization for Eli Lilly's COVID-19 drug baricitinib, saying it could now be used without taking Gilead's drug
Can a glass of wine a day keep a-fib away?
By Megan Brooks NEW YORK (Reuters Health) - Drinking small amounts of red or white wine may help protect against atrial fibrillation, a large observational study suggests. "The relationship between
Olympics-Puberty not sole factor in transgender eligibility says IOC
By Karolos Grohmann TOKYO (Reuters) - Male puberty is not the sole factor in ascertaining whether transgender athletes have an advantage over competitors, the International Olympic Committee's medical
Restoring pulmonary endothelial cells reverses emphysema in mice
By David Douglas NEW YORK (Reuters Health) - Correcting endothelial dysfunction in both human tissue and an elastase-induced murine model of emphysema shows promise in stopping and reversing the
ANALYSIS-Biden's COVID-19 strategy thwarted by anti-vaxxers, Delta variant
By Jeff Mason and Julie Steenhuysen WASHINGTON (Reuters) - When President Joe Biden entered office, his administration made clear it intended to fight the COVID-19 pandemic by focusing on getting the
Majority of Greeks trust COVID vaccines despite protests - poll
By Reuters Staff ATHENS (Reuters) - Nearly two-thirds of Greeks believe getting vaccinated against COVID-19 can beat the pandemic and most favour mandatory vaccination for certain groups such as
Emergent to resume J&J COVID-19 vaccine production at Baltimore plant
By Reuters Staff (Reuters) - Emergent BioSolutions said on Wednesday it will resume production of Johnson & Johnson's COVID-19 vaccine at its troubled Baltimore facility, where operations were stopped
EXCLUSIVE-AstraZeneca COVID-19 vaccine shipped to Canada, Mexico before adequate plant inspections
By Allison Martell, Carl O'Donnell and Cassandra Garrison (Reuters) - Canada and Mexico imported millions of doses of AstraZeneca's COVID-19 vaccine and offered them to the public without health
Israel to offer Pfizer booster shots to people over 60 - Israeli news reports
By Reuters Staff JERUSALEM (Reuters) - Israel will begin offering a third shot of the Pfizer/BioNTech COVID-19 vaccine to people over 60, Israel's Kan public radio and Channel 13 TV said on Thursday.
Heart failure diagnoses often missed in primary care setting
By Lisa Rapaport (Reuters Health) - Many patients with heart failure are not diagnosed until they seek care in an acute setting, particularly female and Black patients, a U.S. study suggests.
Cycling tied to lower all-cause mortality with diabetes
By Lisa Rapaport (Reuters Health) - People with diabetes who cycle frequently, or even occasionally, have lower all-cause and cardiovascular disease mortality than counterparts who don't participate
Viral particle aerosolization during tracheostomy care can be minimized
By Reuters Staff NEW YORK (Reuters Health) - Tracheostomy care leads to significant aerosol generation, but experiments in manikins suggest covering the stoma with a heat moisture exchanger and
Lenvatinib plus gefitinib promising in liver cancer
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with advanced liver cancer who were unresponsive to lenvatinib, adding gefitinib led to a clinically meaningful response in a
Adding 3 extra years of hormone therapy shows no benefit in breast cancer study
By Gene Emery (Reuters Health) - A breast cancer study examining whether longer treatment with an aromatase inhibitor improves outcomes for women with hormone-receptor-positive breast cancer has
Disparities seen in use of standard of care blood thinners for atrial fibrillation
By Linda Carroll (Reuters Health) - Minority patients with atrial fibrillation are less likely to be treated with standard of care blood thinners than white patients, a new study of U.S. Veterans
Babies show no benefit when CMV-positive women get hyperimmune globulin during pregnancy
By Gene Emery (Reuters Health) - Hyperimmune globulin therapy given to pregnant women with a cytomegalovirus (CMV) infection fails to protect their babies from congenital CMV infection or perinatal
New risdiplam results continue to show benefit against type 1 spinal muscular atrophy
By Gene Emery (Reuters Health) - Twelve-month results from part 2 of the FIREFISH study are showing that nearly one third of infants with type 1 spinal muscular atrophy (SMA) who are given the drug
H. pylori may hinder efficacy of immune checkpoint inhibitors
By Marilynn Larkin NEW YORK (Reuters Health) - Helicobacter pylori decreased the efficacy of immune checkpoint inhibitors (ICIs) in mice and was associated with a less efficacious response to ICIs in
CDC says nearly 67% of U.S. counties have substantial, high COVID-19 transmission
By David Shepardson WASHINGTON (Reuters) - The Centers for Disease Control and Prevention (CDC) said on Wednesday that 66.6% of U.S. counties had transmission rates of COVID-19 high enough to warrant
UPDATE 2-Pfizer says 2021 COVID-19 vaccine sales to top $33.5 bln, sees need for boosters
(Adds reference and link to study published on Wednesday, paragraph 6) By Manas Mishra and Michael Erman (Reuters) - Pfizer Inc on Wednesday raised its full-year sales forecast for the COVID-19
UPDATE 1-Pfizer says 2021 COVID-19 vaccine sales to top $33.5 bln, sees need for boosters
(Adds company comment from conference call) By Manas Mishra and Michael Erman (Reuters) - Pfizer Inc on Wednesday raised its full-year sales forecast for the COVID-19 vaccine it developed with
White House tells agencies to mandate masks in federal buildings in hot spots
By David Shepardson WASHINGTON (Reuters) - The White House Office of Management and Budget (OMB) told federal agencies they must mandate masks indoors in federal buildings for all employees and
UPDATE 1-New York to require state employees to get COVID vaccine or face weekly testing
(Updates with announcement details, background) By Maria Caspani NEW YORK (Reuters) - New York will require state employees to be vaccinated against COVID-19 or get tested weekly, a mandate that will
COVID still devastating in the Americas, health agency says
By Reuters Staff BRASILIA (Reuters) - COVID-19 continues to inflict a devastating toll on the Americas, with Argentina, Colombia, Cuba, Ecuador and Paraguay among the countries with the world's
New York to require state employees to be vaccinated or get tested -Cuomo
By Reuters Staff NEW YORK (Reuters) - New York will require state employees to be vaccinated against COVID-19 or get tested, a mandate that will go into effect on Labor Day, Governor Andrew Cuomo said
McConnell aims to boost U.S. Republican vaccination rate by countering 'bad advice'
By David Morgan WASHINGTON (Reuters) - U.S. Senate Republican leader Mitch McConnell blamed misinformation for the low rates of COVID-19 vaccination among Americans, which are fueling a rise in
Biogen withdrew Aduhelm paper after JAMA asked for edits - Axios
By Reuters Staff (Reuters) - Biogen Inc withdrew its paper that analyzed results from the clinical trials of its controversial Alzheimer's drug, Aduhelm, that was submitted to medical journal JAMA,
Olympics-Pandemic takes toll on athlete mental health at Tokyo Games
By Gabrielle Tétrault-Farber and Elaine Lies TOKYO (Reuters) - Isolation and the absence of family and friends have taken a toll on athletes' mental health at the Tokyo Olympics, with some struggling
Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion
By Manas Mishra and Michael Erman (Reuters) - Pfizer Inc on Wednesday raised its full-year sales forecast for the COVID-19 vaccine it developed with Germany's BioNTech by 29% to $33.5 billion, as
CanSinoBIO's inhaled COVID vaccine candidate triggers immune response-early trial
By Reuters Staff BEIJING (Reuters) - An inhaled version of CanSino Biologics' (CanSinoBIO) COVID-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial
Corneal changes may signal long COVID
By Megan Brooks NEW YORK (Reuters Health) - Nerve fiber loss and an increase in immune (dendritic) cells on the surface of the eye may help identify patients with long COVID-19. These corneal changes
Thailand builds COVID-19 hospital in Bangkok airport amid surge in cases
By Juarawee Kittisilpa and Artorn Pookasook BANGKOK (Reuters) - Thai volunteers on Wednesday turned a cargo warehouse at Bangkok's Don Muang Airport into a 1,800-bed field hospital for COVID-19
AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd
By Pushkala Aripaka (Reuters) - AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study
Young adults born small for gestational age have reduced exercise capacity, heart structure changes
By Marilynn Larkin NEW YORK (Reuters Health) - Young adults born small for gestational age (SGA) had lower exercise capacity than their non-SGA peers, as well as right ventricular remodeling, in an
ECT curbs suicide risk after hospitalization for depression, without increasing serious AEs
By Marilynn Larkin NEW YORK (Reuters Health) - Electroconvulsive therapy (ECT) during hospitalization for depression was associated with a reduced risk of suicide afterward and no serious medical
Mental illness tied to COVID-19 severity, death
By Linda Carroll (Reuters Health) - Among patients with COVID-19, those with mental health disorders are more likely to die and to be hospitalized than those without psychiatric or cognitive diagnoses
UPDATE 1-W. Va. city, drug distributors trade final words in landmark opioid trial
(Updates throughout with defense arguments) By Brendan Pierson CHARLESTON (Reuters) - CHARLESTON, W.Va. (Reuters) - Lawyers for a West Virginia city and county hard hit by the opioid crisis began
Biden considers requiring COVID-19 vaccines for federal workers
By Nandita Bose MCLEAN, Va. (Reuters) - President Joe Biden said on Tuesday his administration is considering whether to require U.S. federal employees to be vaccinated against COVID-19. "That's under
UPDATE 2-U.S. CDC recommends vaccinated Americans wear masks indoors in many cases
(Adds reaction, CDC confirmation) By David Shepardson and Julie Steenhuysen WASHINGTON (Reuters) - Americans fully vaccinated against COVID-19 should go back to wearing masks in indoor public places
Young lured to tobacco addiction via e-cigarettes - WHO
By Stephanie Nebehay GENEVA (Reuters) - The tobacco industry's sleek marketing is attracting youngsters to e-cigarettes which can lead to tobacco addiction, despite claims by some executives that they
Support for shorter-course antibiotics in older men with UTI
By Reuters Staff NEW YORK (Reuters Health) - For afebrile men with suspected urinary tract infection (UTI), treatment with ciprofloxacin or trimethoprim/sulfamethoxazole for one week is just as
Atypical COVID symptoms common in older adults
By Megan Brooks NEW YORK (Reuters Health) - New research provides more evidence that older adults with COVID-19 often present with atypical symptoms, including functional decline and altered mental
FEATURE-Greener PPE: Inventors tackle COVID-19 plastic waste mountain
By Emma Batha LONDON (Thomson Reuters Foundation) - From surgical masks and gloves to disposable hospital gowns and aprons, the COVID-19 pandemic is creating a mountain of plastic medical waste that
Physically active lifestyle may protect against obstructive sleep apnea
By Megan Brooks NEW YORK (Reuters Health) - Maintaining an active lifestyle may help protect against obstructive sleep apnea (OSA), according to new research that found higher levels of physical
French government minister injects fellow minister with COVID shot
By Reuters Staff PARIS (Reuters) - Two ministers in the French government promoted the COVID-19 vaccine through their own example on Tuesday, with one of them administering the shot to the other.
Italy says 99% of COVID deaths since Feb were not fully vaccinated
By Reuters Staff MILAN (Reuters) - Almost 99% people who have died of COVID-19 in Italy since February this year were not fully vaccinated, the National Health Institute (ISS) said on Tuesday. The
More U.S. states, employers, schools likely to mandate vaccines, says expert
By Carl O'Donnell (Reuters) - More U.S. states, schools and employers are likely to mandate vaccinations as COVID-19 cases climb but a federal mandate is politically unfeasible, an expert at the
UPDATE 1-CDC set to unveil revised mask guidance for vaccinated Americans -sources
(Adds more background, details on reversal) By David Shepardson WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) is set on Tuesday to recommend fully vaccinated
CDC set to unveil revised mask guidance for vaccinated Americans -sources
By David Shepardson WASHINGTON (Reuters) - The Centers for Disease Control and Prevention (CDC) is set on Tuesday to announce revised mask guidance for fully vaccinated Americans in the wake of rising
UPDATE 1-UK PM Johnson: don't get carried away with falling COVID-19 cases
(Adds interview with second epidemiologist) By Alistair Smout and Sarah Young LONDON (Reuters) - British Prime Minister Boris Johnson said on Tuesday that people should not get carried away by six
West Virginia city makes final pitch in opioid lawsuit seeking $2.5 bln
By Brendan Pierson CHARLESTON (Reuters) - Lawyers for a West Virginia city and its county made their closing arguments on Tuesday in their three-month landmark trial against the nation's largest drug
U.S. FDA approves Merck's Keytruda combo for early breast cancer treatment
By Reuters Staff (Reuters) - Merck & Co Inc said on Tuesday that the U.S. Food and Drug Administration approved its immunotherapy Keytruda as a treatment for an early form of a tough-to-treat breast
REFILE-Light-to-moderate drinking tied to lower risk of heart attack and death in patients with heart disease
By Dania Nadeem (Reuters) - Light-to-moderate alcohol consumption is linked to a reduced risk of heart attack, stroke and death among those with heart disease, according to a study published in the
In Utah, hospitals swell with unvaccinated COVID-19 patients
By Sharon Bernstein (Reuters) - The COVID-19 intensive care unit where nurse Janine Roberts works in a Salt Lake City suburb is once again full, with patients who are mostly young, mostly unvaccinated
Atrial fibrillation after SAVR or TAVR tied to poorer outcome
By David Douglas NEW YORK (Reuters Health) - Following hospital discharge after transcatheter or surgical aortic valve replacement (TAVR or SAVR), atrial fibrillation or flutter (AF) may portend worse
Indonesia considers COVID-19 booster shots for wider use -govt official
By Stanley Widianto JAKARTA (Reuters) - Indonesia, which uses the Sinovac vaccine as its main COVID-19 inoculation, is considering providing a booster shot, as a study showed antibodies provided by
UPDATE 1-Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study
(Updates with study details, comment from Philippine health official, background) By Reuters Staff BEIJING (Reuters) - Antibodies triggered by Sinovac Biotech's COVID-19 vaccine decline below a key
Australia's vaccine rollout 'a colossal failure', ex-PM Turnbull says
By Reuters Staff LONDON (Reuters) - Australia's vaccine rollout has been "a colossal failure" because the government failed to buy enough vaccines so its borders are therefore likely to remain closed
UK PM Johnson: don't get carried away with falling COVID-19 cases
By Alistair Smout and Sarah Young LONDON (Reuters) - British Prime Minister Boris Johnson said on Tuesday that people should not get carried away by six days of better COVID-19 infection data, while
Intensifying therapy with carboplatin boosts survival in group 3 medulloblastoma
By Marilynn Larkin NEW YORK (Reuters Health) - Adding carboplatin to radiation therapy improved survival by 19% at five years among children with group 3 medulloblastoma in a randomized phase 3 trial.
Survival outcomes improving for certain adolescent and young adult cancers
By Lisa Rapaport (Reuters Health) - A growing number of adolescents and young adults are surviving certain cancers that have had high death rates for this age group, including brain cancer, lung
Patients with only smartphone access less likely to use online portals
By Linda Carroll (Reuters Health) - Patients who access the internet only with smartphones are less likely to use patient portal accounts, a new study suggests. An analysis of survey responses from
UPDATE 3-U.S. veterans agency mandates COVID-19 shots for medical staff
(Adds Biden at the White House, details on VA healthcare system, background on COVID-19 cases and Delta variant) By Trevor Hunnicutt WASHINGTON (Reuters) - The U.S. Department of Veterans Affairs on
High humoral response frequent in allogenic HSCT patients after second COVID vaccine dose
By Marilynn Larkin NEW YORK (Reuters Health) - In allogenic hematopoietic stem cell transplant (HSCT) recipients, "frequent and high levels" of humoral responses were seen after two doses of the
Extending the time window for thrombectomy in stroke patients
By Reuters Staff NEW YORK (Reuters Health) - Endovascular thrombectomy (EVT) performed anytime between 6 and 24 hours of ischemic stroke is equally effective in patients who have either a clinical
ARBs a better bet than ACE inhibitors for first-line antihypertensive therapy?
By Megan Brooks NEW YORK (Reuters Health) - For adults initiating antihypertensive drug therapy, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are equally
Russia approves trials of combined AstraZeneca/Sputnik V vaccine
By Reuters Staff MOSCOW (Reuters) - Russia has given the green light for clinical trials combining a British shot from AstraZeneca and Oxford University with Russia's Sputnik V vaccine to go ahead,
UPDATE 2-Veterans agency to require COVID-19 vaccinations for staff
(Adds quote, VA confirmation) By Reuters Staff WASHINGTON (Reuters) - The U.S. Department of Veterans Affairs on Monday said it would require its doctors and other medical staff to get COVID-19
Biden pushes for long COVID sufferers to be protected by law
By Trevor Hunnicutt WASHINGTON (Reuters) - President Joe Biden said Monday the White House is pushing for people with long-term symptoms of COVID-19 to be protected against discrimination, as he
REFILE-UPDATE 1-Biden confirms veterans agency will require COVID-19 vaccinations for staff
(Adds Biden attribution in headline) By Reuters Staff WASHINGTON (Reuters) - U.S. President Joe Biden on Monday confirmed media reports that the federal Veterans Affairs agency will require COVID-19
UPDATE 1-U.S. Veteran Affairs Dept. issues employee vaccine mandate - NYT
(Changes attribution to Biden) By Reuters Staff WASHINGTON (Reuters) - U.S. President Joe Biden on Monday confirmed media reports that the federal Veterans Affairs agency will require COVID-19
Moderna in talks with FDA to expand COVID-19 vaccine pediatric study
By Reuters Staff (Reuters) - Moderna Inc is in talks with U.S. regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between 5 and 11, the drugmaker said on
U.S. Veteran Affairs Dept. issues employee vaccine mandate - NYT
By Reuters Staff WASHINGTON (Reuters) - The U.S. Department of Veterans Affairs will require more than 100,000 of its frontline health care workers to be vaccinated against the coronavirus in the next
Record-smashing heat extremes may become much more likely with climate change -study
By Andrea Januta (Reuters) - Cyprus. Cuba. Turkey. Canada. Northern Ireland. Antarctica. All recorded their hottest-ever temperatures in the last two years, and according to a new study, more such
Loneliness tied to psychiatric, pain drugs, and polypharmacy among older adults
By Lisa Rapaport (Reuters Health) - Older adults who experience loneliness are more likely to take medications for anxiety, depression and pain than peers who feel less lonely, a new study suggests.
UPDATE 1-How the Delta variant upends assumptions about the coronavirus
(Adds details on protective measures against the variant) By Julie Steenhuysen, Alistair Smout and Ari Rabinovitch (Reuters) - The Delta variant is the fastest, fittest and most formidable version of
Israel weighing COVID booster shots for over 60s before FDA approval
By Maayan Lubell JERUSALEM (Reuters) - Israel is considering giving a third shot of the Pfizer/BioNTech COVID-19 vaccine to its elderly population even before FDA approval in order to help fend off
BioNTech aims to develop mRNA-based malaria vaccine
By Reuters Staff BERLIN (Reuters) - BioNTech wants to build on its success in COVID-19 by developing the first vaccine for malaria based on mRNA technology and aims to start clinical testing by the
Oncolytic adenovirus delivered by neural stem cells shows promise against malignant glioma
By Scott Baltic NEW YORK (Reuters Health) - Treatment with an engineered oncolytic adenovirus delivered by neural stem cells appears feasible and safe in patients with malignant gliomas, according to
Most people with an allergic reaction to a first dose of COVID vaccine okay with second dose
By Megan Brooks NEW YORK (Reuters Health) - Most people who have immediate and potentially allergic reactions to the first dose of the Pfizer or Moderna mRNA SARS-CoV-2 vaccine tolerate a second dose,
Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study
By Reuters Staff BEIJING (Reuters) - Antibodies triggered by Sinovac Biotech's COVID-19 vaccine decline below a key threshold from around six months after a second dose for most recipients, although a
Disabled workers fear COVID-19 silver lining to fade as 'old normal' returns
By Catarina Demony PORTO, Portugal (Reuters) - As the world of work shifted during the COVID-19 pandemic towards flexible hours and remote offices, some disabled people who for years have urged
EXCLUSIVE-U.S. will not lift travel restrictions, citing Delta variant -official
By David Shepardson WASHINGTON (Reuters) - The United States will not lift any existing travel restrictions "at this point" due to concerns over the highly transmissible COVID-19 Delta variant and the
Southeast Asia's COVID-19 cases hit new highs, Malaysian doctors protest
By Mei Mei Chu and Artorn Pookasook KUALA LUMPUR/BANGKOK (Reuters) - Thailand reported a record number of coronavirus infections on Monday, while neighbouring Malaysia has more than a million, as the
How the Delta variant upends assumptions about the coronavirus
By Julie Steenhuysen, Alistair Smout and Ari Rabinovitch (Reuters) - The Delta variant is the fastest, fittest and most formidable version of the coronavirus that causes COVID-19 the world has
Some Americans could need COVID-19 vaccine booster -Fauci
By Linda So WASHINGTON (Reuters) - Top infectious disease official Anthony Fauci said on Sunday that Americans who are immune compromised may end up needing COVID-19 vaccine booster shots as the
Onsite contraceptive services curb unintended pregnancies in women with opioid use disorder
By Marilynn Larkin NEW YORK (Reuters Health) - For women with opioid use disorder (OUD) at risk for unintended pregnancy, onsite contraceptive services are likely more effective than usual care, but
Success rates for coronary re-access after TAVR higher in patients with short stent-frame prostheses
By Marilynn Larkin NEW YORK (Reuters Health) - Acute coronary syndrome (ACS) patients who have undergone transcatheter aortic valve replacement (TAVR) may still undergo coronary angiography (CA) or
Vector-based vaccines likely more effective in patients on rituximab
By Marilynn Larkin NEW YORK (Reuters Health) - In patients treated with B cell-depleting rituximab, vector-based vaccines that don't induce a type 1 interferon (IFN-1) response will likely enable a
